FiberSense

FiberSense Secures CE Mark for CGM System: Strategic Entry into European Diabetes Management Market

FiberSense has achieved CE Marking for its Continuous Glucose Monitoring (CGM) System, a Class IIb medical device for adults with diabetes. This approval unlocks market access across the European Union, with initial deliveries slated for late 2026. This development signals a new competitive entrant in the diabetes care sector, necessitating strategic evaluation by procurement and business development teams.